BACKGROUNDChronic transfusion therapy (CTT) for sickle cell anemia (SCA) reduces disease complications by diluting sickle-erythrocytes with hemoglobin A (HbA)-containing erythrocytes and suppressing erythropoiesis. Minor antigen mismatches may result in alloimmunization, but it is unknown if antigen mismatches or recipient characteristics influence HbA clearance post-transfusion.STUDY DESIGN AND METHODSChildren with SCA on CTT were followed prospectively for 12 months. All patients received units serologically matched for C/c, E/e, and K; patients with prior red blood cell (RBC) antibodies had additional matching for Fya, Jkb, and any previous alloantibodies. Patients\u2019 RBC antigen genotypes, determined by PreciseType Human Erythrocyte ...
Red blood cell (RBC) transfusions are widely used in the management of patients with sickle cell dis...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...
BACKGROUNDRed blood cell (RBC) alloimmunization occurs at a high frequency in sickle cell anemia (SC...
Background: Hematopoietic stem cell transplant (HSCT) is the only potential curative therapy for sic...
Chronic transfusion therapy (CTT) for sickle cell disease (SCD) reduces disease morbidity by suppres...
Background: RBC alloimmunization remains a significant problem for many patients with SCD. To reduce...
Chronic red blood cell transfusions remain an essential part of supportive treatment in patients wit...
Chronic red blood cell transfusions remain an essential part of supportive treatment in patients wit...
Background: Patients with SCD are among one of transfused populations more often alloimmunized to re...
Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and...
Background: Sickle cell disease is a very common hemoglobinopathy. The main goal of transfusion ther...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Objective: To evaluate the usefulness of DNA methods to provide a means to precisely genotypically m...
Red blood cell (RBC) transfusions are widely used in the management of patients with sickle cell dis...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...
BACKGROUNDRed blood cell (RBC) alloimmunization occurs at a high frequency in sickle cell anemia (SC...
Background: Hematopoietic stem cell transplant (HSCT) is the only potential curative therapy for sic...
Chronic transfusion therapy (CTT) for sickle cell disease (SCD) reduces disease morbidity by suppres...
Background: RBC alloimmunization remains a significant problem for many patients with SCD. To reduce...
Chronic red blood cell transfusions remain an essential part of supportive treatment in patients wit...
Chronic red blood cell transfusions remain an essential part of supportive treatment in patients wit...
Background: Patients with SCD are among one of transfused populations more often alloimmunized to re...
Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and...
Background: Sickle cell disease is a very common hemoglobinopathy. The main goal of transfusion ther...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Objective: To evaluate the usefulness of DNA methods to provide a means to precisely genotypically m...
Red blood cell (RBC) transfusions are widely used in the management of patients with sickle cell dis...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...
International audienceBACKGROUND:Sickle cell disease (SCD) has become a major public health issue. H...